Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
about
Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical propertiesIn vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.Rad51 supports triple negative breast cancer metastasis.MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma.An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.Variability in melanoma metalloproteinase expression profilingHigh threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2)Changes in expression of VE-cadherin and MMPs in endothelial cells: Implications for angiogenesis.Ellagic Acid, the Active Compound of Phyllanthus urinaria, Exerts In Vivo Anti-Angiogenic Effect and Inhibits MMP-2 ActivityMicroarray and proteomic analysis of breast cancer cell and osteoblast co-cultures: role of osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis.Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.Immunolocalization of MMP9 and MMP2 in osteolytic metastasis originating from MDA-MB-231 human breast cancer cells.FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases.TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition.The tert-butylhydroquinone-mediated activation of the human thioredoxin gene reveals a novel promoter structure.Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.Propoxur enhances MMP-2 expression and the corresponding invasion of human breast cancer cells via the ERK/Nrf2 signaling pathway.Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts.Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.
P2860
Q21246016-24C653D2-B32F-42A7-A31C-D369F4FB98F8Q25257233-38537FE8-7AD3-4F8C-87BD-1A2656C6E71AQ33820604-7208713E-6FB7-447B-A755-9B9B586851F1Q33917622-E57C9D70-2404-4FE0-97A8-1D01FC42F292Q33947759-D46E1CAC-B6A7-4566-98B7-DD2B32EDF561Q34130512-027E9A2F-7EA6-4B3F-B7A9-6EB05A520395Q34296399-96D54D74-65A6-49B0-B14B-BBD87221B260Q34332877-19DC2A2E-BE86-4014-866A-C5B29F214C76Q34608019-5D0159E5-24BF-46D6-A7C1-EEAA2C9846F4Q34983870-AB14C34F-A33E-40D0-AEE8-BD94698F8105Q35310572-BB8F22FE-8218-45EE-8965-68D764D061EBQ36343778-92BB01D1-0959-438A-8674-02162DECBA2AQ36590005-5A006E07-4A47-4346-AD67-340F82201003Q36742135-1FCEDDE3-7AC3-42C5-B403-DCA37D48B7B5Q36857862-8F7E4263-E4BC-45FD-94C6-C77F45A9D687Q37082980-843452AF-B9EB-44AF-B705-E6101C02D70FQ37334058-BED47B63-FB29-48E4-B875-628C62695C6FQ38805723-4D3324BE-B098-4CEF-8856-DA91873CF368Q40277851-3BFA6817-557B-4197-ACA0-9CE32C3E5EEFQ41882913-348AEE26-0365-4737-B61E-D4E5C477B95FQ43244785-C2F6B23B-77FB-427C-9839-8B30F08A8B4FQ43687176-5F36ABC2-206C-4AD9-AD92-A75800CA9656Q45904707-E6F9A0B8-7B73-4D0E-B677-D5ABCE5423FCQ46230430-484EA037-AA9A-469A-81C2-7E62DBAB3022Q48955308-95286947-A46D-4CC7-9589-9357E7539975
P2860
Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Upregulation of matrix metallo ...... r induction of stromal MMP-13.
@en
type
label
Upregulation of matrix metallo ...... r induction of stromal MMP-13.
@en
prefLabel
Upregulation of matrix metallo ...... r induction of stromal MMP-13.
@en
P2093
P2860
P356
P1476
Upregulation of matrix metallo ...... r induction of stromal MMP-13.
@en
P2093
Angela F Drew
Emma C Walker
Emma L de Sousa
Marc A Lafleur
Margaret Bills
Mark Waltham
Tony Blick
P2860
P304
P356
10.1002/IJC.20763
P577
2005-04-01T00:00:00Z